Immunostimulatory Protein LIGHT Holds Promise for Colon Cancer Patients with Poor Prognosis
News
Promoting anti-tumor immunity via the immunostimulatory cytokine LIGHT may highly benefit colon cancer patients whose tumor — having spread to the liver — now face palliative care as their only option. In mice, ... Read more